Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
The synthesis and preliminary pharmacological evaluation of new indole and adamantane amido derivatives is described. The design was based on the pharmacophoric properties of 4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl), 6-[4-(trifluoro methoxy)phenyl]pyridin-3-yl and 4-(trifluoro)phenyl tails, which are present as side chains in the structures of promising drug candidates, currently in clinical tests. These pharmacophores were incorporated into the indole and adamantane scaffolds, respectively. The new derivatives were evaluated for their antimycobacterial potential. The following amides, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-{4-[4(trifluoromethoxy)phenoxy]piperidin-1-yl}benzamide (1 b) and N-{4-[4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl]benzyl}-1H-indolyl-2-carboxamide (2 b), are endowed with antitubercular properties, which merit further investigation.
Paul Joseph Dyson, Valentin Simeonov, Fabien Kuttler, Irina Sinenko